GPX4 and osteoarthritis: It downregulates p53 and upregulates the expression of SLC7A11 and GPX4, suggesting that it improves cartilage degradation in osteoarthritis by inhibiting ferroptosis through the regulation of the p53 signaling pathway, indicating its potential therapeutic effect in osteoarthritis [166].